Protein Kinase Inhibitors (Paperback)

Md. Imtaiyaz Hassan

ISBN 10: 0323912877 / ISBN 13: 9780323912877

Published by Elsevier Science & Technology, Oxford, 2022

About this Item

Paperback. Protein Kinase Inhibitors: From Discovery to Therapeutics Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Seller Inventory # 9780323912877

Bibliographic Details

• Title: Protein Kinase Inhibitors (Paperback)
• Publisher: Elsevier Science & Technology, Oxford
• Publication Date: 2022
• Language: English
• ISBN 10: 0323912877
• ISBN 13: 9780323912877
• Binding: Paperback
• Condition: new

About this title

Synopsis

Protein Kinase Inhibitors: From Discovery to Therapeutics offers a foundational, pragmatic overview of protein kinases inhibitors and their potential role in disease modulation and treatment. Here, international experts in the field offer an integrated discussion of kinase inhibitor biology, biomarker discovery, and methods for drug design and development. After a brief overview of kinases and kinase inhibitors, subsequent chapters discuss individual kinases that are representative of the wider kinases and kinase families, including their roles in disease pathogenesis, underlying mechanisms, potential inhibitors and their modes of action for therapeutic modulation.

Several potential drugs under different stages of clinical trials are discussed, including their relevance to cancer, diabetes, obesity, cardiovascular, neurological, and auto-immune and inflammatory disease, among other disorders. The book also addresses the challenges and opportunities for future kinase inhibitor development.

• Provides a thorough overview of kinase inhibitor biology and its role in disease progression and modulation
• Examines protein kinase inhibitor drugs in various stages of clinical trials and development
• Offers methods and protocols for protein kinase inhibitor research studies and drug design and development
• Includes chapter contributions from international leaders in the field

About the Authors

Dr. Md. Imtaiyaz Hassan, Ph.D., FRSB., FRSC., is a Professor at the Centre for Interdisciplinary Research in Basic Sciences, in Jamia Millia Islamia, New Delhi, India. His research focuses on and design and development of potent and selective kinase inhibitors, as well as understanding the mechanism of folding and dynamic behavior of potential drug targets. Dr. Hassan has published widely in such peer reviewed journals as the International Journal of Biological Macromolecules, Spectrochimica Acta, Scientific Reports, and the OMICS A Journal of Integrative Biology.

Dr. Saba Noor is a Research Associate at the Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India. Dr. Noor has expertise in molecular oncology, and her current research interests lie in development of kinase inhibitors for use in cancer therapeutics. She has published in such peer reviewed journals as Frontiers in Microbiology and International Journal of Biological Macromolecules, among other journals.